A Comparison of the Efficacy of 5 mg Olanzapine and Aprepitant in the Prevention of Multiple-Day Cisplatin Chemotherapy-Induced Nausea and Vomiting
Sign Up to like & getrecommendations! Published in 2022 at "International Journal of Clinical Practice"
DOI: 10.1155/2022/5954379
Abstract: Objective The significance of this article is to talk about aprepitant and olanzapine 5 mg, compare them, and deeply explore the safety or effectiveness during the whole process of multiple-day cisplatin chemotherapy-induced vomiting and nausea. Methods… read more here.
Keywords: olanzapine aprepitant; day cisplatin; cisplatin chemotherapy; chemotherapy ... See more keywords
Clinical Observation of Gene Polymorphism of Olanzapine or Aprepitant in Prevention of CINV
Sign Up to like & getrecommendations! Published in 2021 at "Pharmacogenomics and Personalized Medicine"
DOI: 10.2147/pgpm.s317229
Abstract: Objective The present study aims to investigate the correlation between the gene polymorphisms of the multidrug resistance protein 1 (ABCB1), the intron region of transcriptional factor (GTF2E1) and catechol-O-methyltransferase (COMT), dopamine receptor (DRD2), and the… read more here.
Keywords: cinv; gene; olanzapine aprepitant; olanzapine group ... See more keywords